Reporting risks and benefits of therapy by use of the concepts of unqualified success and unmitigated failure - Applications to highly cited trials in cardiovascular medicine

被引:32
作者
Mancini, GBJ
Schulzer, M
机构
[1] Vancouver Hosp & Hlth Sci Ctr, Vancouver, BC V5E 4Z3, Canada
[2] Univ British Columbia, Dept Med, Vancouver, BC, Canada
[3] Univ British Columbia, Dept Stat, Vancouver, BC, Canada
关键词
number needed to treat; number needed to harm; clinical trials; unqualified success; unmitigated failure; cardiovascular diseases;
D O I
10.1161/01.CIR.99.3.377
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-The NNT (number needed to treat) and NNH (number needed to harm) are useful in conveying the results of clinical trials because they emphasize the effort that must be expended to accomplish a single, tangible outcome. But NNT conveys the effort required to achieve a positive outcome without distinguishing between the presence or absence of treatment-related adverse events. Similarly, NNH conveys harm without accounting for the achievement or lack of achievement of the benefit of therapy. Consequently, a mathematical model was developed to extend the NNT and NNH to represent the effort required to achieve "unqualified success" (NNTUS, treatment success without treatment-induced side effects) and "unmitigated failure" (NNHUF, lack of treatment success with treatment-induced side effects). Methods and Results-NNTUS was calculated by adjusting the absolute risk reduction to allow for the probability of not incurring a treatment-related adverse event. NNHUF was similarly calculated by adjusting the absolute risk of incurring a treatment-related adverse event by the probability of not incurring any treatment-related benefit. The impact of conveying clinical trial data by the use of NNT, NNTUS, NNH, and NNHUF is illustrated by means of 11 highly cited trials identified systematically from the cardiovascular literature. The treatment effort measured by the NNTUS and the NNHUF was consistently higher than that given by the traditional NNT and NNH, These increments ranged from 1% to several hundred percent. Conclusions-The NNTUS and the NNHUF represent the treatment effort required on average to achieve 1 unqualified success and 1 unmitigated failure. NNTUS and NNHUF balance benefit and harm in an objective way and are relevant for making service delivery decisions.
引用
收藏
页码:377 / 383
页数:7
相关论文
共 22 条
[1]  
[Anonymous], 1990, Lancet, V336, P65
[2]  
[Anonymous], [No title captured]
[3]   COSTS AND GAINS IN STROKE PREVENTION - EUROPEAN PERSPECTIVE [J].
ASPLUND, K ;
MARKE, LA ;
TERENT, A ;
GUSTAFSSON, C ;
WESTER, PO .
CEREBROVASCULAR DISEASES, 1993, 3 :34-42
[4]   COMPLETENESS OF REPORTING TRIAL RESULTS - EFFECT ON PHYSICIANS WILLINGNESS TO PRESCRIBE [J].
BOBBIO, M ;
DEMICHELIS, B ;
GIUSTETTO, G .
LANCET, 1994, 343 (8907) :1209-1211
[5]   EFFECT OF PARTIAL ILEAL BYPASS-SURGERY ON MORTALITY AND MORBIDITY FROM CORONARY HEART-DISEASE IN PATIENTS WITH HYPERCHOLESTEROLEMIA - REPORT OF THE PROGRAM ON THE SURGICAL CONTROL OF THE HYPERLIPIDEMIAS (POSCH) [J].
BUCHWALD, H ;
VARCO, RL ;
MATTS, JP ;
LONG, JM ;
FITCH, LL ;
CAMPBELL, GS ;
PEARCE, MB ;
YELLIN, AE ;
EDMISTON, WA ;
SMINK, RD ;
SAWIN, HS ;
CAMPOS, CT ;
HANSEN, BJ ;
TUNA, N ;
KARNEGIS, JN ;
SANMARCO, ME ;
AMPLATZ, K ;
CASTANEDAZUNIGA, WR ;
HUNTER, DW ;
BISSETT, JK ;
WEBER, FJ ;
STEVENSON, JW ;
LEON, AS ;
CHALMERS, TC .
NEW ENGLAND JOURNAL OF MEDICINE, 1990, 323 (14) :946-955
[6]   DIAGNOSIS AND CURE OF THE WOLFF-PARKINSON-WHITE SYNDROME OR PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIAS DURING A SINGLE ELECTROPHYSIOLOGIC TEST [J].
CALKINS, H ;
SOUSA, J ;
ELATASSI, R ;
ROSENHECK, S ;
DEBUITLEIR, M ;
KOU, WH ;
KADISH, AH ;
LANGBERG, JJ ;
MORADY, F .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (23) :1612-1618
[7]  
COHN JN, 1991, NEW ENGL J MED, V325, P3303
[8]   CANADIAN ATRIAL-FIBRILLATION ANTICOAGULATION (CAFA) STUDY [J].
CONNOLLY, SJ ;
LAUPACIS, A ;
GENT, M ;
ROBERTS, RS ;
CAIRNS, JA ;
JOYNER, C .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1991, 18 (02) :349-355
[9]   EFFICACY AND SAFETY OF QUINIDINE THERAPY FOR MAINTENANCE OF SINUS RHYTHM AFTER CARDIOVERSION - A METAANALYSIS OF RANDOMIZED CONTROL TRIALS [J].
COPLEN, SE ;
ANTMAN, EM ;
BERLIN, JA ;
HEWITT, P ;
CHALMERS, TC .
CIRCULATION, 1990, 82 (04) :1106-1116
[10]   MORTALITY AND MORBIDITY IN PATIENTS RECEIVING ENCAINIDE, FLECAINIDE, OR PLACEBO - THE CARDIAC-ARRHYTHMIA SUPPRESSION TRIAL [J].
ECHT, DS ;
LIEBSON, PR ;
MITCHELL, LB ;
PETERS, RW ;
OBIASMANNO, D ;
BARKER, AH ;
ARENSBERG, D ;
BAKER, A ;
FRIEDMAN, L ;
GREENE, HL ;
HUTHER, ML ;
RICHARDSON, DW .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (12) :781-788